Dihydroergotamine
Links shared publicly online about this topic
Orally Inhaled Dihydroergotamine - QualityPoint Technologies
qualitypointtech.net — “A new, orally inhaled preparation of dihydroergotamine may eliminate the complexities associated with DHE administration, offering relief for migraine and other headache sufferers. Future Neurology” View full resource at qualitypointtech.net
Most Recently Shared on June 3, 2011 at 2:45 pm By:
Orally Inhaled Dihydroergotamine: A new, orally inhaled preparation of dihydroergotamine may eliminate the complex... http://bit.ly/lBxid9
Dihydroergotamine-Induced Vasospastic Angina in a Patient Taking a Calcium Channel Blocker (July/August) -- Schenkat et al., 10.1345/aph.1P776 -- The Annals of Pharmacotherapy
theannals.com — “Dihydroergotamine-Induced Vasospastic Angina in a Patient Taking a Calcium Channel Blocker (July/August) -- Schenkat et al., 10.1345/aph.1P776 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on June 22, 2011 at 4:42 am By:
Dihydroergotamine-Induced Vasospastic Angina in a Patient Taking a Calcium Channel Blocker (July/August): OBJECT... http://bit.ly/k6nDe3
Emergency Med Medical News about Migraine Disorders; Posterior Fossa Symptoms
mdlinx.com — “Dihydroergotamine and Its Use in Migraine With Posterior Fossa Symptoms” View full resource at mdlinx.com
Most Recently Shared on June 3, 2010 at 6:38 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Dihydroergotamine and Its Use in Migraine With Posterior Fossa Symptoms: Headache: The Journal of Head ... http://bit.ly/bshbGE #ER #mdlinx
MAP Pharmaceuticals Submits New Drug Application to FDA for Levadex Orally Inhaled Migraine Drug
drugs.com — “Levadex (dihydroergotamine) is a new drug in development for the acute treatment of migraine. Levadex information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on June 1, 2011 at 12:10 am By:
Drugs and Devices OW OW Health
MAP Pharmaceuticals Submits New Drug Application to FDA for Levadex Orally Inhaled Migraine Drug: MOUNTAIN... http://bit.ly/kY3fZf #drug
MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for Levadex
drugs.com — “Levadex (dihydroergotamine) is a new drug in development for the acute treatment of migraine. Levadex information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on August 2, 2011 at 11:08 pm By:
Drugs and Devices OW OW Health
MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for Levadex: MOUNTAIN VIEW, Calif., Aug. 2,... http://bit.ly/pR77XD #drug
MAP Pharmaceuticals Issued U.S. Patent for Methods of Achieving Rapid Relief of Migraine and Minimizing Side Effects Based Upon Pharmacokinetic Profile
drugs.com — “Levadex (dihydroergotamine) is a new drug in development for the acute treatment of migraine. Levadex information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on August 12, 2011 at 3:04 am By:
Drugs and Devices OW OW Health
MAP Pharmaceuticals Issued U.S. Patent for Methods of Achieving Rapid Relief of Migraine and Minimizing Si... http://bit.ly/n2CHeu #drug
Phase 3 studies of Levadex for the acute treatment of migraine - MPR
empr.com — “MAP Pharmaceuticals announced updates on the progress of its Phase 3 development program of Levadex (dihydroergotamine (DHE)), for the acute treatment of migraine.” View full resource at empr.com
Most Recently Shared on May 11, 2010 at 6:47 pm By:
MPR News: Phase 3 studies of Levadex for the acute treatment of migraine: MAP Pharmaceuticals announced updates on... http://bit.ly/ag34SN
Phase 3 study of Levadex for the acute treatment of migraines - MPR
empr.com — “MAP Pharmaceuticals announced completion of a Phase 3 trial of Levadex (dihydroergotamine (DHE)), for the acute treatment of migraine.” View full resource at empr.com
Most Recently Shared on December 22, 2010 at 5:02 pm By:
MPR News: Phase 3 study of Levadex for the acute treatment of migraines: MAP Pharmaceuticals announced completio... http://bit.ly/gGSzSK
NDA Submitted for Levadex for Migraine - ONA
oncologynurseadvisor.com — “MAP Pharmaceuticals announced that it has submitted a NDA to the FDA for Levadex (dihydroergotamine) for the potential acute treatment of migraine in adults.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 27, 2011 at 2:01 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
NDA Submitted for Levadex for Migraine http://goo.gl/fb/k7kM6
NDA Submitted for Levadex for Migraine - MPR
empr.com — “MAP Pharmaceuticals announced that it has submitted a NDA to the FDA for Levadex (dihydroergotamine) for the potential acute treatment of migraine in adults.” View full resource at empr.com
Most Recently Shared on May 27, 2011 at 2:06 pm By:
MPR News: NDA Submitted for Levadex for Migraine: MAP Pharmaceuticals announced that it has submitted a NDA to t... http://bit.ly/miBPWb
Phase 3 study of Levadex for the treatment of migraines - MPR
empr.com — “MAP Pharmaceuticals announced that the efficacy portion of its first Phase 3 trial evaluating its novel migraine therapy, Levadex (dihydroergotamine (DHE)), met all four primary endpoints.” View full resource at empr.com
Most Recently Shared on May 26, 2009 at 7:01 pm By:
MPR News: Phase 3 study of Levadex for the treatment of migraines: MAP Pharmaceuticals announced that t.. http://tinyurl.com/pnn8rq
NuPathe - On A New Route?
rttnews.com — “A splitting headache or migraine can ruin our day. Analgesics like Ibuprofen and Paracetamol, Triptans such as Sumatriptan, Ergotamines like Dihydroergotamine, and Corticosteroids like Dexamethasone are used to treat migraine.” View full resource at rttnews.com
Most Recently Shared on July 17, 2011 at 1:15 pm By:
NuPathe - On A New Route?: A splitting headache or migraine can ruin our day. Analgesics like Ibuprofen and Para... http://bit.ly/qAVlvY
MAP Pharmaceuticals initiates LEVADEX-intravenous DHE comparative trial
news-medical.net — “MAP Pharmaceuticals, Inc. today announced that the Company initiated a trial to compare the pharmacokinetics (PK), safety and metabolic profiles of LEVADEX" orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. LEVADEX is a novel orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine.” View full resource at news-medical.net
Most Recently Shared on February 16, 2010 at 1:02 pm By:
MAP Pharmaceuticals initiates LEVADEX-intravenous DHE comparative trial: MAP Pharmaceuticals, Inc. today announced... http://bit.ly/cQAyXU
Cluster Headache: Headache: Merck Manual Professional
merck.com — “Cluster Headache: Headache: Merck Manual Professional” View full resource at merck.com
Most Recently Shared on August 21, 2009 at 8:23 pm By:
Jeff Kraakevik Neurologist, Physician, and Doctor
Cluster ha= severe unilateral pain around eye w/ autonomic signs. Very short. Male predominance. More info-Merck Man http://bit.ly/vC1F0
Jefferson Headache Center study shows novel, orally inhaled migraine therapy effective
eurekalert.org — “A new study conducted at the Jefferson Headache Center at Thomas Jefferson University Hospital in Philadelphia, Penn., shows an investigational, orally inhaled therapy is effective in treating migraines. The multicenter, phase three FREEDOM-301 trial for the orally inhaled migraine therapy, LEVADEX, shows study participants had significant relief from symptoms such as pain, nausea and light and sound sensitivity when compared to placebo treatment.” View full resource at eurekalert.org
Most Recently Shared on August 11, 2009 at 6:29 pm By:
Study shows inhaled #migraine therapy effective http://ow.ly/jIRp LEVADEX: a novel formulation of dihydroergotamine (DHE)
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
The Annals
The Annals of Pharmacotherapy is a peer-reviewed medical journal advancing drug therapy by publishing evidence-based pharmacy research and clinical reviews.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
